Enlarge / Pfizer headquarters in Manhattan on November 19, 2020. (credit: Getty | Anadolu Agency ) An antiviral pill developed by Pfizer reduced COVID-19 hospitalizations and deaths by about 89 percent in a trial involving 774 newly infected people at risk of developing severe disease. That’s according to a press release posted Friday by the […]
Two London venture investors offer their annual overview of A. I. ‘s evolving landscape. Read More
The drama of the FDA’s approval of Biogen’s Aduhelm is far from over. But what happens next? Read More
There’s another new COVID variant that has the potential to wreak havoc. The key word there is “potential.” Read More
Can a free water bottle and T-shirt convince COVID vaccine skeptics to get their shots? Read More
Convincing COVID vaccine skeptics will be one of the most pressing issues in the coming months. Read More
Convincing COVID vaccine skeptics will be one of the most pressing issues in the coming months. Read More
The biggest threat to Michigan’s COVID control efforts may be politics, not the virus. Read More
The United States has hit a COVID vaccination milestone. But we still need vigilance. Read More
On the most innovative and inventive companies in the pharmaceutical industry, and how things have changed. Read More